Skip to main content

Table 2 Differentially expressed genes common to Leishmania infantum and Leishmania major.

From: Genome-wide gene expression profiling analysis of Leishmania major and Leishmania infantum developmental stages reveals substantial differences between the two species

GO annotation (molecular function)

Accession number (GeneDB) L. infantum

Fold increase

Accession number (GeneDB L. major

Fold increase

Metabolic process

3-ketoacyl-coa thiolase

LinJ23_V3.0860

2,1 a

LmjF23.0690

3,3 a

hydrolase, alpha/beta fold family

LinJ17_V3.1110

1,7 a

LmjF17.1010

1,8 a

vacuolar ATP synthase subunit B

LinJ28_V3.2610

1,8 a

LmjF28.2430

1,7 a

succinyl-coA:3-ketoacid-coenzyme A transferase b

LinJ33_V3.2470

1,8 c

LmjF33.2340

2,1 a

hydrolase, alpha/beta fold family

LinJ17_V3.1110

1,7 c

LmjF17.1010

1,8 c

Carbohydrate metabolic process

acetyl-CoA synthetase

LinJ23_V3.0880

2,0 a

LmjF23.0710

4,5 a

aldose 1-epimerase

LinJ35_V3.1000

1,8 a

LmjF35.0980

2,4 a

enolase

LinJ14_V3.1240

2,3 a

LmjF14.1160

2,4 a

myo-inositol-1-phosphate synthetase

LinJ14_V3.1450

2,4 c

LmjF14.1360

4,7 c

Lipid metabolic process

3-oxo-5-alpha-steroid 4-dehydrogenase

LinJ25_V3.1850

1,7 a

LmjF25.1770

3,0 a

fatty acid elongase

LinJ14_V3.0700

2,0 a

LmjF14.0670

3,2 a

lathosterol oxidase

LinJ23_V3.1560

1,9 a

LmjF23.1300

3,6 a

phosphoglycan beta 1,3 galactosyltransferase

LinJ02_V3.0140

1,8 a

LmjF02.0160

3,8 a

phosphoglycan beta 1,3 galactosyltransferase d

 

22,0 c

 

2,4-11,8 c

hypothetical

LinJ13_V3.0200

2,7 c

LmjF13.0200

3,8 c

Nucleobase, nucleoside, nucleotide and nucleic acid metabolic process

adenylosuccinate synthetase

LinJ13_V3.1090

1,8 a

LmjF13.1190

2,0 a

 

LinJ25_V3.1210

   
 

LinJ25_V3.2580

 

LmjF25.1170,

 

ATPase beta subunit

LinJ25_V3.2590

2,1 a

LmjF25.1180

1,9 a

DNA metabolic process

3'-nucleotidase/nuclease

LinJ12_V3.0350

2,0 a

LmjF12.0400

3,9 a

3'-nucleotidase/nuclease precursor

LinJ31_V3.2380

1,7 a

LmjF31.2310

4,6 a

histone 1

LinJ33_V3.3390

2,6 a

LmjF33.3240

1,9 a

3'-nucleotidase/nuclease

LinJ31_V3.2370

2,0 c

LmjF31.2300

1,7 c

double-strand-break repair protein rad21

LinJ05_V3.1090

3,0 c

LmjF05.1090

1,9 c

RNA metabolic process

exosome complex exonuclease RRP45

LinJ22_V3.1430

3,1 c

LmjF22.1580

1,8 c

RNA-binding protein 5

LinJ09_V3.0080

3,4 c

LmjF09.0060

1,7 c

Amino acid and derivative metabolic process

glutamate dehydrogenase

LinJ15_V3.1070

1,8 a

LmjF15.1010

1,8 a

Protein metabolic process

HSP 70

LinJ32_V3.2050

2,0 a

LmjF32.1940

1,9 a

Proteolysis

 

LinJ14_V3.0910,

   

calpain-like cysteine peptidase

LinJ14_V3.0920

1,7 a

LmjF14.0850

4,5 a

calpain-like cysteine peptidase

LinJ20_V3.1320

2,0 a

LmjF20.1280

2,1 a

calpain-like cysteine peptidase

LinJ20_V3.1350

1,7 a

LmjF20.1310

2,9 a

calpain-like cysteine peptidase

LinJ27_V3.2490

1,8 a

LmjF27.0510

2,8 a

calpain-like cysteine peptidase

LinJ32_V3.1020

1,8 a

LmjF32.0970

1,9 a

   

LmjF01.0830,

 
   

LmjF02.0740,

 

peptidyl-dipeptidase

LinJ02_V3.0710

1,7 a

LmjF27.2660

2,5 a

puromycin-sensitive aminopeptidase-like

LinJ12_V3.0830

2,1 c

LmjF12.1250

1,8 c

Protein modification process

protein kinase A catalytic subunit

LinJ18_V3.1090

1,9 a

LmjF18.1080

3,2 a

protein kinase A regulatory subunit

LinJ13_V3.0160

2,5 a

LmjF13.0160

2,1 a

protein kinase

LinJ30_V3.1780

2,5 c

LmjF30.1780

1,7 c

Electron transport

trypanothione synthetase

LinJ23_V3.0500

1,7 c

LmjF23.0460

1,8 c

Cellular component organization and biogenesis

dynein heavy chain

LinJ13_V3.1390

1,7 a

LmjF13.1650

2,1 a

dynein heavy chain

LinJ26_V3.1000

1,9 a

LmjF26.1020

1,7 a

dynein heavy chain

LinJ28_V3.0650

1,8 a

LmjF28.0610

2,0 a

dynein heavy chain (pseudogene)

LinJ27_V3.2460

2,1 a

LmjF27.2590

2,0 a

dynein light chain

LinJ24_V3.1050

2,0 a

LmjF24.1030

2,0 a

dynein-associated roadblock

LinJ35_V3.1740

1,8 a

LmjF35.1750

2,1 a

OSM3-like kinesin

LinJ17_V3.0890

1,7 a

LmjF17.0800

2,0 a

Cell motility

   

LmjF39.1750,

 
 

LinJ29_V3.1880,

 

LmjF29.1760

 

PFR 1D

LinJ29_V3.1890

3,9 a

LmjF29.1770

4,5 a

 

LinJ16_V3.1510,

 

LmjF16.1425,

 

PFR 2C

LinJ16_V3.1520

3,7 a

LmjF16.1430

5,3 a

paraflagellar rod component

LinJ09_V3.1390

1,9 a

LmjF09.1320

2,8 a

Cell communication

   

LmjF09.0910,

 
 

LinJ09_V3.0970,

 

LmjF09.0920

 

calmodulin

LinJ09_V3.0980

2,0 a

LmjF09.0930

2,8 a

calmodulin

LinJ13_V3.1060

1,8 a

LmjF13.1160

1,8 a

receptor-type adenylate cyclase a

LinJ17_V3.0120

1,7 a

LmjF17.0200

1,8 a

   

LmjF17.0230,

 
 

LinJ17_V3.0140,

 

LmjF17.0235

 

receptor-type adenylate cyclase b

LinJ17_V3.0160

1,8 a

LmjF17.0237

2,6 a

Transport

amino acid transporter aATP11 b

LinJ31_V3.0370

2,4 c

LmjF31.0350

4,7 a

phosphate-repressible phosphate permease

LinJ03_V3.0480

1,7 c

LmjF03.0500

2,0 c

Unclassified

oxidoreductase

LinJ36_V3.4380

1,7 a

LmjF36.4170

1,7 a

leucine rich repeat protein

LinJ32_V3.3200

1,7 a

LmjF32.3010

2,2 a

leucine rich repeat protein

LinJ10_V3.0160

2,1 a

LmjF10.0180

2,3 a

protein tyrosine phosphatase

LinJ05_V3.0280

1,8 a

LmjF05.0280

2,6 a

hypothetical

LinJ01_V3.0640

2,4 a

LmjF01.0620

2,3 a

hypothetical

LinJ02_V3.0520

3,9 a

LmjF02.0550

5,0 a

hypothetical

LinJ07_V3.0040

2,0 a

LmjF07.0030

1,8 a

hypothetical

LinJ07_V3.0470

1,8 a

LmjF07.0310

2,7 a

hypothetical

LinJ09_V3.1620

2,1 a

LmjF09.1530

1,8 a

hypothetical

LinJ10_V3.1370

1,9 a

LmjF10.1230

1,9 a

hypothetical

LinJ11_V3.0620

2,0 a

LmjF11.0610

2,1 a

hypothetical

LinJ11_V3.1040

2,1 a

LmjF11.1040

2,0 a

hypothetical

LinJ17_V3.0970

2,0 a

LmjF17.0870

3,6 a

hypothetical

LinJ18_V3.1640

3,5 a

LmjF18.1640

6,6 a

hypothetical

LinJ19_V3.0520

4,5 a

LmjF19.0520

5,9 a

hypothetical

LinJ20_V3.0760

1,7 a

LmjF20.0700

1,8 a

hypothetical

LinJ21_V3.0440

1,8 a

LmjF21.0380

2,5 a

hypothetical

LinJ23_V3.1190

2,0 a

LmjF23.1020

4,6 a

hypothetical

LinJ24_V3.1630

4,1 a

LmjF24.1560

4,1 a

hypothetical

LinJ24_V3.2200

2,4 a

LmjF24.2110

1,8 a

hypothetical

LinJ26_V3.2400

2,1 a

Lm jF26.2380

3,0 a

hypothetical

LinJ27_V3.0720

1,9 a

LmjF27.0870

1,7 a

hypothetical

LinJ28_V3.1150

2,1 a

LmjF28.1060

2,9 a

hypothetical

LinJ29_V3.0360

1,7 a

Lm jF29.0350

1,9 a

hypothetical

LinJ29_V3.1090

2,4 a

Lm jF29.1000

3,0 a

hypothetical

LinJ29_V3.1190

2,0 a

Lm jF29.1100

1,8 a

hypothetical

LinJ29_V3.1260

2,5 a

Lm jF29.1170

3,2 a

hypothetical

LinJ29_V3.2940

2,5 a

Lm jF29.2830

3,7 a

hypothetical

LinJ30_V3.2870

4,4 a

Lm jF30.2850

8,5 a

hypothetical

LinJ31_V3.1220

2,7 a

LmjF31.1200

2,0 a

hypothetical

LinJ32_V3.0360

1,7 a

Lm jF32.0350

2,0 a

hypothetical

LinJ32_V3.0370

2,2 a

Lm jF32.0360

2,2 a

hypothetical

LinJ32_V3.1840

2,2 a

Lm jF32.1760

3,0 a

hypothetical

LinJ32_V3.2020

2,8 a

Lm jF32.1910

2,4 a

hypothetical

LinJ33_V3.0660

3,7 a

Lm jF33.0610

5,4 a

hypothetical

LinJ34_V3.1620

2,0 a

Lm jF34.1520

4,0 a

hypothetical

LinJ34_V3.2590

1,7 a

LmjF34.2760

1,8 a

hypothetical

LinJ34_V3.4230

1,9 a

Lm jF34.4600

3,0 a

hypothetical

LinJ35_V3.5310

2,4 a

Lm jF35.5340

4,0 a

hypothetical

LinJ36_V3.0800

2,4 a

LmjF36.0740

1,8 a

hypothetical

LinJ36_V3.3000

1,8 a

Lm jF36.2850

2,0 a

hypothetical

LinJ36_V3.3780

1,8 a

Lm jF36.3620

6,7 a

hypothetical

LinJ36_V3.4440

4,1 a

Lm jF36.4230

5,7 a

hypothetical

LinJ36_V3.5010

2,7 a

Lm jF36.4780

3,2 a

hypothetical

LinJ36_V3.5140

2,3 a

LmjF36.4910

1,9 a

hypothetical

LinJ36_V3.5210

1,8 a

LmjF36.4980

2,5 a

hypothetical

LinJ35_V3.3780

1,8 c

LmjF35.3730

1,7 a

   

LmjF 23.1050,

 
 

LinJ23_V3.1210,

 

LmjF 23.1080,

 

SHERP b

LinJ23_V3.1230

2,5 c

LmjF23.1086

1,7 a

Amastins e

 

1.9–6.8 c

 

1.9–25.4 c

   

LmjF 05.1230,

 
   

LmjF19.1650

 

GIPL galf transferase

LinJ32_V3.4140

2,8 c

LmjF32.3990

2,0 c

hypothetical

LinJ01_V3.0650

1,7 c

LmjF01.0630

2,5 c

hypothetical

LinJ06_V3.1030

2,1 c

LmjF06.0995

1,8 c

hypothetical

LinJ08_V3.0650

2,0 c

Lm jF08.0640

4,8 c

hypothetical

LinJ10_V3.1130

2,7 c

LmjF10.1050

1,8 c

hypothetical

LinJ12_V3.0440

1,9 c

Lm jF12.0480

5,1 c

hypothetical

LinJ16_V3.0100

1,9 c

Lm jF16.0090

2,5 c

hypothetical

LinJ24_V3.2320

2,7 c

LmjF24.2230

1,7 c

hypothetical

LinJ25_V3.2870

2,3 c

LmjF35.2820

1,8 c

hypothetical

LinJ26_V3.1440

1,8 c

Lm jF26.1460

2,0 c

hypothetical

LinJ27_V3.0770

20,8 c

Lm jF27.0910

1,9 c

hypothetical

LinJ27_V3.2320

2,5 c

LmjF27.2370

1,8 c

hypothetical

LinJ30_V3.0820

2,0 c

LmjF30.0770

1,8 c

hypothetical

LinJ30_V3.1000

7,1 c

LmjF30.0940

2,7 c

hypothetical

LinJ30_V3.2340

1,7 c

Lm jF30.2330

2,4 c

hypothetical

LinJ31_V3.1190

2,1 c

Lm jF31.1170

2,7 c

hypothetical

LinJ 31_V 3.2140

1,9 c

LmjF 31.2090

2,0 c

hypothetical

LinJ 32_V3.3600

1,9 c

LmjF 32.3400

2,3 c

hypothetical

LinJ 33_V3.1720

4,2 c

Lm jF 33.1620

4,5 c

hypothetical

LinJ 35_V3.5130

1,7 c

Lm jF 35.5160

1,8 c

  1. a Genes differentially expressed in promastigotes.
  2. b Genes differentially expressed but not in the same life stage.
  3. c Genes differentially expressed in amastigotes.
  4. d The majority of the phosphoglycan 1,3 galactosyltransferase gene family members are differentially expressed in amastigotes. These genes are listed in Additional files 2 and 4.
  5. e The majority of the amastin gene family members are differentially expressed in amastigotes. These genes are listed in Additional files 2 and 4.